Pictet Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471M Buy
1,853,258
+392,729
+27% +$91.5M 0.45% 46
2026
Q1
$357M Sell
1,460,529
-29,789
-2% -$6.94M 0.38% 56
2025
Q4
$308M Buy
1,490,318
+51,447
+4% +$10.2M 0.3% 77
2025
Q3
$267M Sell
1,438,871
-38,327
-3% -$6.57M 0.26% 98
2025
Q2
$226M Buy
1,477,198
+57,770
+4% +$8.88M 0.23% 107
2025
Q1
$235M Sell
1,419,428
-3,054
-0.2% -$478K 0.26% 100
2024
Q4
$206M Buy
1,422,482
+155,308
+12% +$24.1M 0.22% 112
2024
Q3
$205M Buy
1,267,174
+6,994
+0.6% +$1.11M 0.23% 117
2024
Q2
$184M Buy
1,260,180
+7,594
+0.6% +$1.13M 0.21% 117
2024
Q1
$198M Buy
1,252,586
+3,116
+0.2% +$496K 0.22% 122
2023
Q4
$196M Sell
1,249,470
-15,545
-1% -$2.38M 0.22% 126
2023
Q3
$197M Buy
+1,265,015
New +$209M 0.24% 116

Other funds holding JNJ

Pictet Asset Management's JNJ Position: Q2 2026 in Review

Pictet Asset Management increased its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, buying an estimated $91.5M and bringing the position to 1,853,258 shares worth $471M. The position accounts for 0.45% of the portfolio, ranked #46.

Pictet Asset Management first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Pictet Asset Management held 1,853,258 shares of Johnson & Johnson worth $471M as of Q2 2026.
  • Pictet Asset Management bought 392,729 Johnson & Johnson shares in Q2 2026, an estimated $91.5M.
  • Johnson & Johnson made up 0.45% of Pictet Asset Management's portfolio in Q2 2026, its #46 holding.
  • Pictet Asset Management first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.